Cognis Achieves NSF Certification
Cognis Nutrition & Health received good manufacturing practices (GMPs) registration for its Covtiol vitamin E, Vegapure phytosterol, and Tonalin conjugated linoleic acid ingredients, the company announced on August 4. NSF International (Ann Arbor, MI) awarded the certification to Cognis’ production facilities in Kankakee, IL, and Illertissen, Germany, after conducting an intensive plant audit. NSF also will conduct periodic audits in the future.
Cognis Nutrition & Health received good manufacturing practices (GMPs) registration for its Covtiol vitamin E, Vegapure phytosterol, and Tonalin conjugated linoleic acid ingredients, the company announced on August 4.
NSF International (Ann Arbor, MI) awarded the certification to Cognis’ production facilities in Kankakee, IL, and Illertissen, Germany, after conducting an intensive plant audit. NSF also will conduct periodic audits in the future.
“The registration provides an invaluable benefit for our dietary supplement customers,” said David Hessler, quality assurance leader for Cognis Nutrition & Health. “As a world leader in supplying the finest health-enhancing ingredients, Cognis has taken the initiative to complete this rigorous process to ultimately make GMP conformance easier for dietary supplement manufacturers by making sure we’re in compliance so they are as well. As a result of our affirmed compliance, this certification will help our customers eliminate the need for costly and time-consuming plant audits.”
Senate Committee has released the text of 2024 Farm Bill, with changes to hemp regulations
November 19th 2024The U.S. Senate Committee on Agriculture, Nutrition, & Forestry has introduced the Rural Prosperity and Food Security Act, which will serve as the Senate’s draft for the 2024 Farm Bill.
NPA’s lawsuit against FDA on NMN stayed pending agency’s decision on citizen petition
November 6th 2024The court has granted a joint motion for stay filed by NPA and FDA, pending the agency's decision on the citizen petition asking FDA to reverse its stance on NMN's status as a dietary ingredient.
